Involucrin is a marker of keratinocyte terminal differentiation and is expressed only in the suprabasal layers of stratified squamous epithelium. In a previous study with various cell types in culture, we noted that expression of the putative human involucrin promoter was keratinocyte specific. To determine if this promoter is sufficient to direct expression to the suprabasal cells of stratified squamous epithelia in vivo, we have now generated transgenic mouse lines harboring the involucrin promoter sequences linked to a (3ga-lactosidase reporter gene. In the resulting lines, -galactosidase was expressed in the suprabasal compartment of stratified squamous epithelia and in hair follicles in a tissue-specific manner. In the palate, distinct vertical stacks of 3galacto-sidase-expressing cells were present, suggesting movement of clonally derived ceUs through the epithelium. The involucrin gene has a single intron upstream of the translational start site, and removal of this intron did not affect tissue-or stratumspecific expression. These results show that the 3.7-kb involucrin upstream sequences contain all the information necessary for a high level of tissue-and stratum-specific expression.
Keratinocytes in stratified squamous epithelia exhibit specific patterns of gene expression as they undergo a progressive terminal differentiation during movement from the basal layer to the surface (1, 2) . One gene expressed in suprabasal cells of this tissue encodes involucrin (3) . Involucrin is a component of the cornified envelope of stratified squamous epithelia (3) (4) (5) and is a substrate, as are other envelope precursors, for transglutaminase-mediated enzymatic crosslinking (for reviews see refs. 6 and 7). In humans, the involucrin gene has been shown to consist of a short noncoding exon, a single intron, and a single exon containing the entire coding region (8) . Although much is known about the function and evolution of involucrin protein (9) , little is known about how the involucrin gene is regulated, other than a recent report of a phorbol 12-myristate 13-acetateresponsive element in the promoter (10) .
The onset of involucrin protein expression in vitro is related to the appearance ofinvolucrin RNA in differentiating keratinocytes (11) . Although involucrin protein is detected at various levels of stratification depending on the site of tissue origin, it is invariably expressed at some point in the spinous layer (12) . Unlike other markers of terminal differentiation, such as the K1/K10 keratins (13) or loricrin (14) , involucrin appears to be resistant to the effects of agents which alter keratinocyte gene expression. For example, involucrin is synthesized in submerged cultures of keratinocytes (3) even though in these cultures there is no K1/K10 (15) , no loricrin (16) , few cornified envelopes, and no stratum corneum. Even when stratification is inhibited by low concentrations of
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. calcium in the medium, involucrin continues to be expressed in a small fraction of cells in the basal layer (17) . In raft cultures, where tissue differentiation is improved, treatment with retinoic acid suppresses both loricrin and transglutaminase expression (14, 18) , whereas in the intact skin applications of retinoic acid result in an apparent increase in involucrin staining (19) . In healing epidermis (20) , as well as psoriasis (21, 22) , there is gross disruption of keratinocyte differentiation, yet involucrin expression appears prematurely but within the confines of the spinous layer. Because involucrin expression in normal epidermis is likely to be regulated at the transcriptional level (11) , analysis of its promoter is likely to provide insights into why involucrin is not regulated in the same way as other markers of differentiation.
In an in vitro study of the involucrin upstream region we noted that a 3.7-kb fragment conferred keratinocyte-specific expression in transient assays (23) . To determine ifthis 3.7-kb fragment encoded tissue and stratum specificity, transgenic mouse lines were generated with this construct linked to a ,B3galactosidase ((3gal) carried out by using standard protocols (24) . For mouse screenings, genomic DNA was isolated from ears of 4-weekold mice and polymerase chain reaction (PCR) analysis was performed with (3-gal primers. Primers to the (3-gal (lacZ) gene were chosen to yield a fragment of 680 bp (upstream primer, 5'-TGCGTGACTACCTACGGGTAACAGT; downstream primer, 5'-GATCGACAGATTTGATCCAG-CGATA). DNA-positive lines were then histochemically screened for 5-bromo-4-chloro-3-indolyl (-D-galactoside (XGal) expression in the tail epidermis (see X-Gal Histochemistry below). One founder (368-2) with intense (3-gal staining was outbred to generate an F1 line which was used for all subsequent analysis.
Southern Analysis. Genomic DNA isolated from tails was digested with BamHI, which cuts twice within the transgene to yield a 4-kb band, and the resultant DNA was electrophoresed on a 1% agarose gel. After blotting to nitrocellulose, filters were incubated with a 635-bp 32P-labeled (-gal probe, washed, and exposed to x-ray film. Copy number was estimated by comparing band intensities, as measured with a laser densitometer, to known standards of the 4.0-kb (-gal fragment, and variations in loading were assessed by reprobing the blots for the single-copy (3-actin gene band.
RNA Analysis. Total RNA was isolated from the organs of 4-to 10-week-old F1 mice by using RNAzolB reagent (Cinna/ Biotecx Laboratories, Houston), followed by digestion with DNase I and precipitation with ethanol. A reverse transcriptase (RT)-PCR kit (Perkin-Elmer/Cetus) and random primers were used to amplify 0.5 ,g of total RNA to cDNA. Half of the reaction mixture was subjected to PCR using 3gal primers and half to PCR using actin primers to determine if comparable amounts of RNA were present in all tissues. The (-gal primers yielded a 680-bp band, and the actin primers yielded a 217-bp band. RNA was mock-PCR amplified (no reverse transcription) to ensure that all traces of DNA were removed. X-Gal Histochemistry. Tissue was harvested from mice and placed overnight in a solution of 30o sucrose in PBS. The next day tissue samples were snap frozen at -70°C in O.C.T. embedding compound (Tissue-Tek, Miles) and 8-,um-thick sections were cut by using a Reichert Histostat Cryostat (model 855) and placed on gelatin-coated slides. Sections were postfixed for 10 min in 2% paraformaldehyde, washed, and stained en face with X-Gal (25) . After staining in X-Gal solution for 2 hr at 37°C, slides were rinsed and counterstained by means of the Feulgen reaction (using the Schiff reagent). Nontransgenic mouse tissues were also stained to assess endogenous (3-gal activity.
RESULTS
Generation of Transgenic Mice. Transgenic mice were generated with an expression vector containing the involucrin upstream sequence, an SV40 intron, the (-gal coding region, and an SV40 poly(A)+ sequence (Fig. 1A and ref. 23 ).
Three to five weeks after birth, 35 founder mice were screened for (3-gal sequences and 4 positive mice were detected. These were further screened for (-gal expression by using X-Gal histochemical staining on tail skin. Transgene copy number in the DNA-positive founders was determined by Southern analysis and was 2-50 copies per cell (Fig. 2) . The intensity of X-Gal staining in tail skin did not correlate with transgene copy number. For example, line 359-2 with approximately 42 copies per cell had very light X-Gal staining, whereas line 353-6 with approximately 2 copies per cell had quite intense staining. Line 368-1, which was negative for (3gal DNA, was also negative for X-Gal staining. Mouse line 368-2 was chosen for further study as preliminary examination of tail skin showed that staining was more intense and more uniformly distributed than in the other founder mice. Line 368-2 had approximately 41 copies of the transgene per cell. To avoid the possibility of mosaic expression sometimes seen in founder mice (26) , all further analysis ofline 368-2 was performed on F1 offspring derived by mating with outbred strain C3H.
Tissue-and Stratum-Specific Transgene Expression. To determine the tissue distribution of transgene expression, total RNA was isolated from various tissues of mouse line 368-2 and subjected to RT-PCR amplification. Results are shown in Fig. 3 tissues or organs which have stratified squamous epithelia. However, in brain, heart, and liver, organs which have no stratified squamous epithelia, the 680-bp band was not detected. These results indicate that transgene expression was tissue specific.
Histochemical staining of the skin of tail, dorsum, maxilla, ear, penis, and footpad indicated that the transgene was always expressed in the suprabasal layer, beginning at some point in the spinous layer. This is illustrated for the skin of the tail and dorsum, where a uniform and intense blue staining was seen throughout the suprabasal layers (Fig. 4 A and B) . Hair follicles were also noted to stain intensely, and the location of staining (data not shown) was similar to that noted for involucrin protein in human hair follicles (27) . Internal organs with simple epithelia-liver, kidney, and lungs-were negative for (3-gal expression, as was muscle. The stratified squamous epithelia of internal organs (palate, buccal mucosa, tongue, esophagus, forestomach, and cervix) were positive, as was the stratified urothelium of bladder. Three of thesepalate, buccal mucosa, and cervix-are shown in Fig. 4 C, D , and E. X-Gal staining was generally present in the suprabasal layers, although the staining pattern of these internal epithelia was somewhat less uniform than in the epidermis. In fact, in the hard palate, stacks of stained cells appeared as a cluster of one or several cells, beginning in the immediate suprabasal layer and extending upwards to the surface as an expanding vertical column of cells (see arrows in Fig. 4C ). These ordered stacks are reminiscent of the vertical columns of cornified cells seen in normal mouse epidermis (28) . Close examination of the base of these columns suggests that basal cells exhibit (3-gal staining, but it is not certain if the basal location of these cells is a result of the plane of tissue section.
These histochemical results indicate that the 3.7-kb involucrin promoter sequence can direct stratum-specific expression in vivo and, when considered along with the RNA expression pattern (Fig. 3) , confirm tissue-specific expression.
The involucrin gene has a single intron located between the transcriptional and translational start sites (8) . In transient assays in cultured keratinocytes, removal of this intron results in a dramatic reduction of expression (23) . As introns in this upstream location site are known to have regulatory activity (29), we queried if the involucrin intron was required for tissue-and stratum-specific expression. Several lines of mice were constructed with 2.5 kb of involucrin upstream sequences without the involucrin intron (Fig. 1B) Fig. 4F) . Staining in the epidermis of line 367-2 was patchy and noticeably less intense compared with staining in line 368-2. It is evident that the involucrin intron is not required for stratum-specific expression. The reduced levels of transgene expression in mouse line 367-2 made an analysis of tissue specificity less meaningful, but when expression was detected, either by histochemistry or by RNA analysis (data not shown), it was always in stratified squamous epithelia. The involucrin intron is therefore not essential for tissue-specific expression, although its presence in the promoter appears to ensure high expression in all tissues.
DISCUSSION
To determine if a 3.7-kb segment of DNA upstream of the involucrin coding region was sufficient for tissue-and stratum-specific expression in vivo, this segment was linked to a ,(3gal reporter gene and used in the construction oftransgenic mice. Expression in the resulting mice was confined to the suprabasal cells of stratified squamous epithelium, thereby demonstrating its promoter regulatory role in vivo. The involucrin promoter thereforejoins with the human K5, K14, and Ki promoters, as well as the bovine K10 promoter, in being correctly expressed with both tissue and stratum specificity in stratified epithelia of transgenic mice (26, (30) (31) (32) .
In human epidermis, as well as in the epidermis of transgenic mice, K14 is expressed in the basal layer, while Kl and K10 are expressed in the suprabasal cells (33) . The K14 promoter has been particularly useful in exploring the pathological consequences of expression of a mutant of K14 keratin and in identifying human disease correlates of this keratin (34) . Although a 12-kb fragment of the Kl promoter gives correct tissue-and stratum-specific expression in transgenic mice, it fails to respond as the endogenous mouse Kl promoter to modulators of keratinocyte differentiation, suggesting that additional sequences are needed to mediate the correct responses (31) . As discussed in the introduction, involucrin is constitutively expressed during differentiation and is not subject to modulation in the same way as are other markers of differentiation. Analysis of the involucrin transgene promoter is therefore likely to lead to clues as to how these different forms of regulation are achieved.
Involucrin (35) ip.
bL . . -, -% ordered movement of progeny through the tissue. This also marks the first time of which we are aware that an EPU-type organization has been seen in oral mucosa. The lack of a stratum corneum in this noncornifying tissue has prevented visualization of ordered columns of cornified cells, as is found in the epidermis. A similar columnar pattern has been seen in transgenic mice in which a K14-directed transgene was expressed in a mosaic fashion in the basal layer of the epidermis and the resulting transgene product was carried along in the progeny cells in the overlying spinous layer (26) . Because the involucrin promoter is faithfully expressed in all stratified squamous epithelia and is insensitive to environmental influences, it might be particularly well suited as a vehicle for keratinocyte-mediated gene therapy (43) . This might be valuable for potential medical applications, including drug delivery and correction of epidermal disease states. The fact that expression from the involucrin promoter is confined to suprabasal spinous and granular cells may also allow targeting of the new gene product to specific strata while sparing the basal population of cells.
Note Added in Proof. Similar tissue-and differentiation-specific results have been obtained with the human involucrin promoter in transgenic mice. See Crish et al. (44) .
